Recombinant antibodies inhibit enzymatic activity of the E3 ubiquitin ligase CHIP via multiple mechanisms
Journal of Biological Chemistry · 2025
DOI: 10.1016/j.jbc.2025.108220 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Dong Hee Chung und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, USA. Electronic address: dhnc86@gmail.com. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Immunoglobulin Fab Fragments. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, NIGMS NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
Carboxyl-terminus of Hsp70-Interacting Protein (CHIP) is an E3 ubiquitin ligase that marks misfolded substrates for degradation. Hyper-activation of CHIP has been implicated in multiple diseases, including cystic fibrosis and cancer, suggesting that it may be a potential drug target. However, there are few tools available for exploring this possibility. Moreover, the best ways of inhibiting CHIP's function are not obvious, as this complex protein is composed of a tetratricopeptide repeat (TPR) domain, a U-box domain, and a coiled-coil domain that mediates homodimerization. To probe the structure and function of CHIP, we report an antibody panning campaign that yielded six recombinant Fabs with affinity for CHIP. Interestingly, these antibodies varied in their binding site(s) and impact on CHIP function, such as inhibiting TPR interactions, autoubiquitination, and/or substrate ubiquitination. Of particular interest, antibody 2F1 nearly eliminated substrate binding (IC50 = 2.7 μM) and limited ubiquitination and autoubiquitination. Cryo-electron microscopy of the 2F1:CHIP complex revealed a 2:1 binding mode (Fab:CHIP dimer), with 2F1 bound to the U-box domain and simultaneously displacing the TPR domain. Together, these studies provide insight into ways of inhibiting CHIP's activity and provide a series of new probes for exploring the function of this important E3 ubiquitin ligase.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, USA. Electronic address: dhnc86@gmail.com.
- Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, California, USA.
- Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, California, USA.
- Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, USA.
- Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, USA; Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, Californ…
- Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, California, USA; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, Calif…
Förderung
- NINDS NIH HHS
- NIGMS NIH HHS
- NIA NIH HHS
- NIAID NIH HHS
- National Institute of Neurological Disorders and Stroke
- National Institute of Allergy and Infectious Diseases Division of Intramural Research
- National Institutes of Health
- University of California, San Francisco
Zitieren
APA
Chung, D. H., Connelly, E. J., Unnikrishnan, A., Chuo, S. W., Wucherer, K., Nadel, C. M., Gestwicki, J. E., Southworth, D. R., & Craik, C. S. (2025). Recombinant antibodies inhibit enzymatic activity of the E3 ubiquitin ligase CHIP via multiple mechanisms. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.108220
Vancouver
Chung DH, Connelly EJ, Unnikrishnan A, Chuo SW, Wucherer K, Nadel CM, et al. Recombinant antibodies inhibit enzymatic activity of the E3 ubiquitin ligase CHIP via multiple mechanisms. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.108220
BibTeX
@article{Chung2025,
author = {Chung, Dong Hee and Connelly, Emily J and Unnikrishnan, Aparna and Chuo, Shih-Wei and Wucherer, Kristin and Nadel, Cory M and Gestwicki, Jason E and Southworth, Daniel R and Craik, Charles S},
title = {Recombinant antibodies inhibit enzymatic activity of the E3 ubiquitin ligase CHIP via multiple mechanisms},
journal = {Journal of Biological Chemistry},
year = {2025},
doi = {10.1016/j.jbc.2025.108220}
}
EUVIMED